Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081340 | SCV000113268 | benign | not specified | 2013-08-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081340 | SCV000169835 | benign | not specified | 2014-05-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV000301562 | SCV000450675 | likely benign | Autosomal dominant nonsyndromic hearing loss 6 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000361228 | SCV000450676 | likely benign | WFS1-Related Spectrum Disorders | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Laboratory for Molecular Medicine, |
RCV000081340 | SCV000711255 | benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | Gly786Ser in Exon 08 of WFS1: This variant is not expected to have clinical sign ificance because it has been identified in 0.6% (22/3698) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs71578980). |
Invitae | RCV000872722 | SCV001014581 | likely benign | not provided | 2023-12-31 | criteria provided, single submitter | clinical testing | |
Personalized Diabetes Medicine Program, |
RCV001174427 | SCV001337565 | benign | Monogenic diabetes | 2019-02-08 | criteria provided, single submitter | research | ACMG criteria: BP4 (REVEL 0.142 + 8 predictors; not using PP3/2 predictors), BS2 (20 cases and 19 controls in type2diabetesgenetics.org), BS1 (0.75% MAF in Africans in gnomAD)= benign |
Clinical Genomics, |
RCV002464007 | SCV002605297 | benign | Wolfram syndrome 1 | criteria provided, single submitter | research | Potent mutations in WFS1 gene are associated with Wolfram's syndrome, an autosomal recessive condition, which cause diabetes mellitus, diabetes insipidus, deafness and optic atrophy.However no sufficient evidence is found to ascertain the role of this particular variant rs71578980 yet. | |
Ce |
RCV000872722 | SCV004147646 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | WFS1: BP4 |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000872722 | SCV001956912 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000872722 | SCV001966610 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000872722 | SCV002036801 | likely benign | not provided | no assertion criteria provided | clinical testing |